Şunu aradınız:: inhibition (İngilizce - Svahili)

later, remdesivir also demonstrated possible inhibition of other single stranded rna viruses including mers and sars viruses.
baadaye, remdesivir pia ilionyesha kuzuia uwezekano wa kutokea virusi vingine vya rna vya namna moja ikiwa ni pamoja na virusi vya mers na sars.

by this reasoning, inhibition of nlrp3 inflammasome with mcc950 might be useful in the treatment of covid-19.
kwa mantiki hii, uzuiaji wa nlrp3 inflammasome kwa kutumia mcc950 kunaweza kuwa muhimu katika matibabu ya covid-19.

interestingly, the nucleotide analogue remdesivir is known to suppress cov replication through inhibition of this exoribonuclease and the rna-dependent rna polymerase.
jambo la kupendeza ni kuwa, dawa ya nucleotide analogue remdesivir inafahamika kudidimisha uzalishaji wa cov kupitia uzuiaji wa eksoribonuklisi na rna polimerisi inayotegemea rna.

this entry process also requires priming of the s protein by the host serine protease tmprss2, the inhibition of which is under current investigation as a potential therapeutic.this has led some to hypothesize that decreasing the levels of ace2, in cells, might help in fighting the infection.
mchakato huu wa kuingia unahitaji pia utayarishaji wa protini s na vizuia protini vya serine kuu ya tmprss2, uzuiaji ambao unachunguzwa kwa sasa kama matibabu yanayowezekana. hii imesababisha wengine kudhania kwamba kupunguza viwango vya ace2, katika seli, kunaweza kusaidia kukabiliana na maambukizi.

nitazoxanide has been recommended for further in vivo study after demonstrating low concentration inhibition of sars-cov-2.studies have demonstrated that initial spike protein priming by transmembrane protease serine 2 (tmprss2) is essential for entry of sars-cov-2 via interaction with the ace2 receptor.
nitazaxonide imependekezwa kwa utafiti zaidi wa vivo baada ya kuonyesha uzuizi wa kiwango cha chini cha ukolezo wa sars-cov-2. utafiti umeonyesha kwamba ongezeko la maandalizi ya protini kwa kutumia transmembrane protease serine 2 (tmprss2) ni muhimu kwa uingiaji wa sars-cpv-2 kupitia mtagusano na vipokezi vya ace2.